Clarify the Role of Kynmobi for Parkinson's Disease
February 2021
Kynmobi (apomorphine) sublingual film will be a new option for "off" episodes in Parkinson's disease.
It's a quick-acting dopamine agonist...for symptoms (tremor, etc) that return between carbidopa/levodopa doses, especially in advanced Parkinson's disease.
Kynmobi will be used "on demand"...similar to Movapo (apomorphine) subcutaneous injection.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive